Introduction Paediatric occupational therapy seeks to improve children's engagement and
participation in life roles. A wide variety of intervention approaches exist. Our aim was to …

Aim The aim of this study was to describe systematically the best available intervention
evidence for children with cerebral palsy (CP). Method This study was a systematic review of …

Cerebral palsy is the most common cause of physical disability affecting children in
developed countries, with an incidence of 2.0 to 2.5 per 1000 live births. 1 It is not a single …

Cerebral palsy (CP) is caused by a static lesion to the brain occurring in utero or up to the
first 2 years of life; it often manifests as musculoskeletal impairments and movement …

In this study we assessed the distribution of spasticity, range of motion (ROM) deficits, and
selective motor control problems in children with cerebral palsy (CP), and examined how …

Everyday functioning is described in 95 children with cerebral palsy (CP; 55 males and 40
females; mean age 58 months, SD 18 months, range 25 to 87 months) using the three …

Botulinum neurotoxin type‐A (BoNT‐A) has been used in association with other
interventions in the management of spasticity in children with cerebral palsy (CP) for almost …

Aim To systematically review the efficacy of interventions on upper limb function in children 0
to 19 years of age with bilateral cerebral palsy on the basis of outcome measures of upper …

Botulinum toxin type A (BoNT-A) therapy has gained wide acceptance in the management of
spasticity in cerebral palsy (CP). Clinical experience from numerous case reports and series …

This article reviews the current best evidence for musculoskeletal interventions in children
with ambulatory cerebral palsy (CP). The effectiveness of interventions in CP must first …